GENFIT S.A. (GNFT) Financials

GNFT Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 ? ?
2023-06-30 210.8 million 129.8 million
2023-03-31 234.9 million 131.9 million
2022-12-31 231.3 million 129.9 million

GNFT Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 ? ?
2023-06-30 -30.3 million 148964
2023-03-31 -28.5 million 52865
2022-12-31 ? ?

GNFT Net Income

No data available :(

GNFT Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 - - -
2023-06-30 121.6 million - 6.6 million
2023-03-31 153.2 million - -
2022-12-31 150.8 million - 7.0 million

GNFT Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 ?
2023-06-30 54.0 million
2023-03-31 54.1 million
2022-12-31 53.5 million

GNFT Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 - - - -
2023-06-30 2.2 million 27.1 million 5.0 million 282707
2023-03-31 - 19.2 million 4.5 million 289941
2022-12-31 - - - -

GNFT Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 3.0 million -
2023-06-30 12.5 million 4.3 million
2023-03-31 6.6 million -
2022-12-31 6.5 million -

GNFT

Price: $3.50

52 week price:
2.89
4.75

Earnings Per Share: -0.83 USD

P/E Ratio: -4.40

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 944

Market Capitalization: 177.9 million

Links: